| Business Summary | | Gene
Logic,
Inc.
is
a
supplier
of
integrated
genomic
information
and
bioinformatics
related
to
gene
activity
in
human
disease
and
toxicity
to
enable
global
pharmaceutical,
biotechnology,
life
sciences
and
diagnostic
companies
to
reduce
the
time,
risk
and
cost
involved
in
developing
drugs
against
human
disease.
Through
the
systematic
and
industrialized
application
of
genomics,
the
Company
has
built
and
is
commercializing
what
it
believes
to
be
the
world's
most
comprehensive
survey
of
gene
expression
from
human
and
animal
tissues.
The
Company
markets
a
growing
portfolio
of
gene
expression-based
products.
These
products
include
the
Company's
flagship
product,
the
GeneExpress
Suite
of
databases,
and
custom,
proprietary
gene
expression
databases
focused
on
single
disease
indications. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | GLGC
provides
genomic
information,
enabling
the
discovery
and
development
of
pharmaceutical,
biotechnology,
and
life
science
products
through
the
systematic
and
industrialized
application
of
genomics.
For
the
six
months
ended
6/30/01,
revenues
rose
47%
to
$17.8
million.
Net
loss
before
acct.
change
totaled
$20
million,
up
from
$9.5
million.
Results
reflect
increased
subscriptions
for
the
GeneExpressTM,
offset
by
increased
tissue
acquisition
and
processing
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Mark Gessler, 39 Chairman,
Pres, CEO | $888K | $5.6M | Philip Rohrer, Jr., 44 CFO | -- | -- | Victor Markowitz, 48 Sr.
VP, CIO | 400K | 938K | Eric Eastman,P.h.D., 48 Sr.
VP, CTO | 286K | 183K | David Murray, 54 Sr.
VP, Marketing and Sales | 603K | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|